Tokyo, Japan

Tatumi Hiramoto


 

Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Tokyo, JP (2005 - 2006)
  • Tokyo-to, JP (2013)

Company Filing History:


Years Active: 2005-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Tatumi Hiramoto

Introduction

Tatumi Hiramoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of phototherapy and semiconductor technology. With a total of 4 patents to his name, Hiramoto's work has had a substantial impact on medical and technological advancements.

Latest Patents

Hiramoto's latest patents include a phototherapy apparatus using excimer radiation. This innovative device enhances therapeutic effects while minimizing harm by utilizing a XeCl excimer lamp to irradiate diseased skin sites with UV-B radiation. An optical filter is employed to modify the spectral shape of the UV-B radiation, optimizing treatment for skin disorders. Another notable patent is for an extreme UV radiation source and semiconductor exposure device. This device emits usable 13.5 nm radiation using tin (Sn) as the radiation substance. It allows for rapid transport to the plasma generation site while suppressing the formation of detrimental debris and vapor coagulation.

Career Highlights

Hiramoto is associated with Ushio Denki Kabushiki Kaisha, a company known for its advancements in lighting and photonic technologies. His work has been instrumental in developing innovative solutions that address complex challenges in the medical and semiconductor fields.

Collaborations

Hiramoto has collaborated with notable colleagues such as Kazuaki Hota and Taku Sumitomo. Their combined expertise has contributed to the success of various projects and patents.

Conclusion

Tatumi Hiramoto's contributions to innovation in phototherapy and semiconductor technology highlight his role as a leading inventor. His patents reflect a commitment to enhancing therapeutic methods and advancing technological capabilities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…